Ritcema
Brand Name: Ritcema™
Composition: Rituximab Injection 500 mg / 50 mL
Product Description
Medical Info
Ritcema™ is a high-strength, prescription-only therapeutic biological medication containing 500 mg of Rituximab in a 50 mL vial. Classified as a chimeric monoclonal antibody, it is designed to target and bind specifically to the CD20 antigen found on the surface of both normal and malignant B-cells. This targeted mechanism leads to B-cell depletion, making it a vital medical intervention for treating specific cancers like Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia, as well as severe autoimmune disorders like Rheumatoid Arthritis. Manufactured under Celon Laboratories, Ritcema™ is intended strictly for intravenous (I.V.) infusion within clinical settings under specialist oncological or rheumatological supervision.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
